510(k) Report

510(k) · Cleared

Cleared

Careside CKMB

K990434510(k) TraditionalCleared Apr 19, 199967-day reviewClass II21 CFR 862.1215

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Careside, Inc. · JHS Differential Rate Kinetic Method, Cpk Or Isoenzymes

Cleared on Apr 19, 1999 as substantially equivalent to K912844 (Eastman Kodak Company, 1991) after a 67-day review. Its family tree reaches back 1 generation to 1991.

Decided
Apr 19, 1999
Review
67 days
Class
Class II
Product code
JHS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K912844 (1991). No later device cites it as a predicate yet.

K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 1991199019921994199619982000
K912844 · Kodak Ektachem Dtii System · Eastman Kodak Company · 19910
  1. Root · 1 generation backK912844 Kodak Ektachem Dtii SystemEastman Kodak Company · 1991
  2. This deviceK990434 Careside CKMBCareside, Inc. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K912844Kodak Ektachem Dtii SystemEastman Kodak Company1991—
0 (this device)K990434Careside CKMBCareside, Inc.1999—
FIG. 1 — Lineage of K990434, 1991–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JHS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K912844Kodak Ektachem Dtii System
Summary page 1
…hnson’s (formerly Eastman Kodak, Inc.) Vitros CKMB Slides for Johnson and Johnson’s Vitros DTSC module of the Vitros DT I1 system (formerly Eastman Kodak’s DTSC 60 II). K912844/A unknown CARESIDE, Inc. CARESIDE™ CKMB Premarket Notification Page 11 Iv. January 29, 1999 Device Descriptio…
Eastman Kodak Company1991—

Also cleared against K912844: 28 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 28 other devices also cite its predicate K912844.

How does its category compare?

All JHS devices

JHS Differential Rate Kinetic Method, Cpk Or Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JHS

1in 2016

2008: 12011: 12016: 1
2007high 1 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JHS

Too few JHS 510(k)s in any year since 2007 to give a median.

Recalls per year · JHS

1in 2020

2013: 22018: 52020: 1
2007high 5 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JHS

10in 2025

2008: 52009: 112010: 262011: 182012: 12013: 22014: 32015: 32016: 12017: 12018: 62019: 62020: 132021: 42022: 32023: 122024: 142025: 10
2007high 26 (2010) · low 0 (2007)2025

MAUDE reports naming product code JHS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—05
20090—011
20100—026
20111—018
20120—01
20130—22
20140—03
20150—03
20161—01
20170—01
20180—56
20190—06
20200—113
20210—04
20220—03
20230—012
20240—014
20250—010
20260—0—

What is it indicated for?

For in vitro diagnostic use with the CARESIDE Analyzer™ to measure CK-MB from whole blood, serum or plasma specimens to aid in the diagnosis and treatment of patients with myopathic disorders including myocardial infarction, myocarditis, Duchenne’s muscular dystrophy, polymyosititis, and rhabdomyolysis.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K990434: Careside CKMB.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K990434

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026